TMCLIFE | TMC LIFE SCIENCES BERHAD
0.695 (0.0%)
T-O (am): 0.000 (08:59:00)
Last updated: 09:54
Fundamental
Technical
Total Score
iSaham Fundamental Trend
FCON: | Sharpe Ratio: | LTS:
Quarter Reports
Select columns required and click "Update" to save your preferences
| Ann. Date | Qtr. Date | Q | FYE | Revenue [M] | PBT [M] | NP [M] | NPM | DPS | EPS | R. QoQ | R. YoY | E. QoQ | E. YoY | TTM EPS |
Adj. [M] |
NP [M] (adj) |
NPM (adj) |
EPS (adj) |
E. QoQ (adj) |
E. YoY (adj) |
TTM EPS (adj) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 02 Feb 24 | Q2 Dec 23 | 2 | 30 Jun 24 | 93.78 | 19.68 | 14.52 | 15.5% | 0.00 | 0.83 | 1.5% | 27.9% | 4.1% | 164.6% | ||||||||
| 14 Nov 23 | Q1 Sep 23 | 1 | 30 Jun 24 | 92.44 | 20.14 | 15.14 | 16.4% | 0.00 | 0.87 | 9.2% | 28.6% | 14.3% | 143.1% | ||||||||
| 22 Aug 23 | Q4 Jun 23 | 4 | 30 Jun 23 | 84.65 | 12.59 | 13.24 | 15.7% | 0.84 | 0.76 | 3.8% | 19.6% | 7.3% | 43.6% | ||||||||
| 23 May 23 | Q3 Mar 23 | 3 | 30 Jun 23 | 81.58 | 11.89 | 14.29 | 17.5% | 0.00 | 0.82 | 11.2% | 33.6% | 160.4% | 105.1% | ||||||||
| 08 Feb 23 | Q2 Dec 22 | 2 | 30 Jun 23 | 73.34 | 7.68 | 5.49 | 7.5% | 0.00 | 0.32 | 2.0% | 23.9% | 11.8% | 20.5% | ||||||||
| 16 Nov 22 | Q1 Sep 22 | 1 | 30 Jun 23 | 71.87 | 8.73 | 6.23 | 8.7% | 0.00 | 0.36 | 1.5% | 36.4% | 73.5% | 53.9% | ||||||||
| 23 Aug 22 | Q4 Jun 22 | 4 | 30 Jun 22 | 70.80 | 10.35 | 23.47 | 33.1% | 0.28 | 1.35 | 15.9% | 32.6% | 236.8% | 525.3% | ||||||||
| 26 May 22 | Q3 Mar 22 | 3 | 30 Jun 22 | 61.08 | 7.46 | 6.97 | 11.4% | 0.00 | 0.40 | 3.1% | 27.2% | 0.9% | 110.2% | ||||||||
| 09 Feb 22 | Q2 Dec 21 | 2 | 30 Jun 22 | 59.22 | 9.05 | 6.91 | 11.7% | 0.00 | 0.40 | 12.4% | 21.4% | 70.7% | 27.9% | ||||||||
| 09 Nov 21 | Q1 Sep 21 | 1 | 30 Jun 22 | 52.68 | 5.32 | 4.05 | 7.7% | 0.00 | 0.23 | 1.3% | 3.6% | 7.8% | 48.0% | ||||||||
| 24 Aug 21 | Q4 Jun 21 | 4 | 30 Jun 21 | 53.37 | 5.70 | 3.75 | 7.0% | 0.22 | 0.22 | 11.1% | 253.3% | 13.2% | 34.0% | ||||||||
| 25 May 21 | Q3 Mar 21 | 3 | 30 Jun 21 | 48.03 | 4.37 | 3.32 | 6.9% | 0.00 | 0.19 | 1.6% | 37.7% | 38.6% | 177.1% | ||||||||
| 04 Feb 21 | Q2 Dec 20 | 2 | 30 Jun 21 | 48.79 | 6.98 | 5.40 | 11.1% | 0.00 | 0.31 | 4.0% | 4.1% | 30.6% | 20.8% | ||||||||
| 10 Nov 20 | Q1 Sep 20 | 1 | 30 Jun 21 | 50.83 | 10.62 | 7.78 | 15.3% | 0.00 | 0.45 | 236.5% | 3.2% | 178.0% | 2.1% | ||||||||
| 25 Aug 20 | 30 Jun 20 | Other | 30 Jun 20 | 15.11 | 3.68 | 2.80 | 18.5% | 0.17 | 0.16 | 56.7% | 70.7% | 165.1% | 56.7% | ||||||||
| 28 Jul 20 | 31 May 20 | Other | 30 Jun 20 | 34.87 | -4.55 | -4.30 | -12.3% | 0.00 | -0.25 | 31.5% | 31.8% | 163.0% | 151.5% | ||||||||
| 28 Apr 20 | 29 Feb 20 | Other | 30 Jun 20 | 50.89 | 8.63 | 6.82 | 13.4% | 0.00 | 0.39 | 3.1% | 12.7% | 14.2% | 9.9% | ||||||||
| 09 Jan 20 | 30 Nov 19 | Other | 30 Jun 20 | 52.53 | 10.66 | 7.95 | 15.1% | 0.00 | 0.46 | 2.0% | 11.4% | 23.1% | 12.5% | ||||||||
| 24 Oct 19 | Q4 Aug 19 | 4 | 31 Aug 19 | 51.52 | 9.63 | 6.46 | 12.5% | 0.20 | 0.37 | 0.8% | 16.0% | 22.7% | 14.9% | ||||||||
| 26 Jul 19 | Q3 May 19 | 3 | 31 Aug 19 | 51.13 | 10.89 | 8.36 | 16.3% | 0.00 | 0.48 | 13.2% | 28.8% | 34.7% | 75.6% | ||||||||
| 23 Apr 19 | Q2 Feb 19 | 2 | 31 Aug 19 | 45.16 | 8.22 | 6.21 | 13.7% | 0.00 | 0.36 | 4.2% | 8.2% | 12.2% | 1.9% | ||||||||
| 24 Jan 19 | Q1 Nov 18 | 1 | 31 Aug 19 | 47.16 | 9.41 | 7.07 | 15.0% | 0.00 | 0.41 | 6.2% | 20.0% | 25.6% | 36.3% | ||||||||
| 26 Jul 18 | Q3 May 18 | 3 | 31 Aug 18 | 44.41 | 8.00 | 5.63 | 12.7% | 0.00 | 0.32 | 11.8% | 9.1% | 18.2% | 5.5% | ||||||||
| 30 Apr 18 | Q2 Feb 18 | 2 | 31 Aug 18 | 39.71 | 6.40 | 4.76 | 12.0% | 0.00 | 0.27 | 4.8% | 11.8% | 24.8% | 4.8% | ||||||||
| 29 Jan 18 | Q1 Nov 17 | 1 | 31 Aug 18 | 41.73 | 8.32 | 6.33 | 15.2% | 0.00 | 0.36 | 6.2% | 15.3% | 43.0% | 42.6% | ||||||||
| 26 Oct 17 | Q4 Aug 17 | 4 | 31 Aug 17 | 39.31 | 6.75 | 11.10 | 28.2% | 0.17 | 0.64 | 3.4% | 16.3% | 86.3% | 89.0% | ||||||||
| 27 Jul 17 | Q3 May 17 | 3 | 31 Aug 17 | 40.69 | 8.02 | 5.96 | 14.6% | 0.00 | 0.34 | 14.6% | 16.6% | 31.1% | 10.5% | ||||||||
| 28 Apr 17 | Q2 Feb 17 | 2 | 31 Aug 17 | 35.51 | 6.27 | 4.54 | 12.8% | 0.00 | 0.26 | 1.9% | 13.1% | 2.4% | 38.8% | ||||||||
| 23 Jan 17 | Q1 Nov 16 | 1 | 31 Aug 17 | 36.20 | 6.11 | 4.44 | 12.3% | 0.00 | 0.26 | 7.1% | 15.5% | 24.4% | 33.0% | ||||||||
| 28 Oct 16 | 31 Aug 16 | Other | 31 Aug 16 | 33.80 | 5.42 | 5.87 | 17.4% | 0.15 | 0.34 | 3.2% | 12.4% | 8.9% | 102.8% | ||||||||
| 28 Jul 16 | 31 May 16 | Other | 31 Aug 16 | 34.91 | 6.43 | 5.39 | 15.4% | 0.00 | 0.32 | 11.2% | 22.5% | 64.5% | 35.3% | ||||||||
| 21 Apr 16 | 29 Feb 16 | Other | 31 Aug 16 | 31.39 | 4.85 | 3.27 | 10.4% | 0.00 | 0.21 | 0.2% | 18.8% | 1.9% | 12.7% | ||||||||
| 22 Jan 16 | 30 Nov 15 | Other | 31 Aug 16 | 31.33 | 4.88 | 3.34 | 10.7% | 0.00 | 0.24 | 4.2% | 24.8% | 15.3% | 44.7% | ||||||||
| 21 Oct 15 | 31 Aug 15 | Other | 31 Aug 16 | 30.07 | 4.35 | 2.89 | 9.6% | 0.00 | 0.24 | 5.5% | 29.8% | 27.3% | 297.5% | ||||||||
| 24 Jul 15 | Q4 May 15 | 4 | 31 May 15 | 28.50 | 2.64 | 3.98 | 14.0% | 0.14 | 0.40 | 7.9% | 17.7% | 37.0% | 48.5% | ||||||||
| 22 Apr 15 | Q3 Feb 15 | 3 | 31 May 15 | 26.41 | 3.20 | 2.91 | 11.0% | 0.00 | 0.32 | 5.2% | 19.5% | 26.0% | 66.7% | ||||||||
| 22 Jan 15 | 30/11/14 | 2 | 31/05/15 | 25.10 | 2.12 | 2.31 | 9.2% | 0.00 | 0.28 | 8.3% | 10.8% | 216.9% | 3.9% |
Historical Dividends
Financial Ratios
| EPS | 3.3 sen |
| Trailing PE (Sector Median: 22.4) | 21.1 |
| PEG | 0.21 |
| Altman Z | 0.8 |
| Beaver | 0.16 |
| Current Ratio | 1.96 |
| Debt-Equity (DE) Ratio | 0.36 |
| FCF Yield | 3.46 % |
| Revenue QoQ | 1.46 % |
| Revenue YoY | 27.87% |
| Profit QoQ | -4.07 % |
| Profit YoY | 164.55 % |
| Profit Margin (Sector Median: 7.4) | 16.23 % |
| ROE (ROIC: 5.34) | 6.52 % |
| Dividend Per Share (DPS) | 0.84 sen |
| Dividend Yield (DY) | 1.21 % |
Adjusted Financial Ratios
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 22.4) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 7.4) | |
| ROE (ROIC: 5.36) | |
| Altman Z |
Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 0.5 | Consistent QR FV |
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | 14.56 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 319.15 |
| Expected Revenue (M) | 2690.98 |
| Expected Growth (%) | 43.0 |
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research
Directors Share Purchases (Beta)
No transaction in the last 2 months.
Summary
Market Cap: 1206 M.
Number of Shares: 1736 M.
Adjusted Float: 100%.
Stock highly correlated with
EDARAN (88%)
UNIQUE (88%)
CRESNDO (87%)
PBA (87%)
TMC Life Sciences Berhad, through its subsidiaries, provides a range of fertility treatment services in Malaysia. It is engaged in the development, marketing, management of healthcare programs; provision of storage of cord blood and adult stem cells, stem cell therapy, and application services. It operates women's clinic and medical center; and provides gynecological and fertility problem management, as well as consultancy, and research and development services. The company operates TMC fertility centers. The company was founded in 1994 and is headquartered in Petaling Jaya, Malaysia.
Sectors: Trading & Services, Healthcare, Health Care Providers
Code: 0101
Website: http://www.tmclife.com/
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
No warrants listed
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.